A Multicenter, Open-Label, Extension Trial to Assess the Long-Term Use of Lacosamide Monotherapy and Safety of Lacosamide Monotherapy and Adjunctive Therapy in Subjects with Partial-Onset Seizures (SP904)

Grants and Contracts Details

StatusFinished
Effective start/end date3/23/109/30/14

Funding

  • Schwarz BioSciences Inc: $1,260.00